These findings highlight the critical role of the USP10-MRPS7/MRPS23 molecular axis as both a key driver of nasopharyngeal carcinoma progression and a novel actionable target for precision oncology approaches. This evidence concerns the gene MRPS23 and nasopharyngeal carcinoma.